May 13, 2013 at 10:37 AM EDT
UPDATE: Credit Suisse Upgrades Sequenom to Neutral on Lessened Risks
In a report published Monday, Credit Suisse analyst Vamil Divan upgraded the rating on Sequenom (NASDAQ: SQNM ) from Underperform to Neutral, and slightly raised the price target from $4.00 to $4.50. In the report, Divan noted, “Following daily moves in SQNM's stock can get one dizzy, but after seven
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here